RenovoRx, Inc. (RNXT) stock
RNXTNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30124% above fair value
$1.04−0.12 (-10.34%)
Close on Nov 13, 2026Market cap $46.93MP/E –Yield –
RenovoRx EV/EBITDA
EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.
No ev/ebitda figures for RenovoRx
RenovoRx has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?